112 related articles for article (PubMed ID: 24283043)
1. [Prognostic significance of p53 expression in patients with mammary gland cancer].
Shchurov NF; Pogorelaia TIu; Zaplatina SV
Klin Khir; 2013 Jul; (7):36-8. PubMed ID: 24283043
[TBL] [Abstract][Full Text] [Related]
2. [FACTORS OF PROGNOSIS IN PATIENTS WITH EARLY CANCER OF MAMMARY GLAND].
Shchurov MF; Voloshyna NM; Pogorila TY
Klin Khir; 2015 Dec; (12):38-40. PubMed ID: 27025030
[TBL] [Abstract][Full Text] [Related]
3. [THE ROLE OF TUMORAL STROMA IN PREDICTING OF THE SEVERITY COURSE IN PATIENTS, SUFFERING MAMMARY GLAND CANCER WITH P53 HYPEREXPRESSION].
Shchurov NF
Klin Khir; 2015 May; (5):61-4. PubMed ID: 26419039
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G
Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the X-linked inhibitor of apoptosis protein for invasive ductal breast cancer with triple-negative phenotype.
Wang J; Liu Y; Ji R; Gu Q; Zhao X; Liu Y; Sun B
Hum Pathol; 2010 Aug; 41(8):1186-95. PubMed ID: 20381828
[TBL] [Abstract][Full Text] [Related]
6. Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program.
Schwartz AM; Henson DE; Chen D; Rajamarthandan S
Arch Pathol Lab Med; 2014 Aug; 138(8):1048-52. PubMed ID: 25076293
[TBL] [Abstract][Full Text] [Related]
7. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
Zhang B; Liu FF; Ma YJ; Gu F
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.
Balogh GA; Mailo DA; Corte MM; Roncoroni P; Nardi H; Vincent E; Martinez D; Cafasso ME; Frizza A; Ponce G; Vincent E; Barutta E; Lizarraga P; Lizarraga G; Monti C; Paolillo E; Vincent R; Quatroquio R; Grimi C; Maturi H; Aimale M; Spinsanti C; Montero H; Santiago J; Shulman L; Rivadulla M; Machiavelli M; Salum G; Cuevas MA; Picolini J; Gentili A; Gentili R; Mordoh J
Int J Oncol; 2006 Apr; 28(4):995-1002. PubMed ID: 16525651
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance.
Malik FA; Sanders AJ; Jones AD; Mansel RE; Jiang WG
Int J Mol Med; 2009 Feb; 23(2):273-8. PubMed ID: 19148553
[TBL] [Abstract][Full Text] [Related]
12. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
Meenakshi A; Manoharan V
Hum Antibodies; 1999; 9(3):171-6. PubMed ID: 10690631
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer].
Castiglioni T; Elsner B; Curutchet HP; Montesinos M; Debonis D
Medicina (B Aires); 1995; 55(5 Pt 1):415-20. PubMed ID: 8728771
[TBL] [Abstract][Full Text] [Related]
14. [Notch1 mRNA and protein expression in human breast cancer and normal mammary gland tissues].
Hua BL; Fu XG; Hu WH; Yin L; Kang XL; Li HA; Jiang JF; Li F
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):806-9. PubMed ID: 20193454
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
Song M; Li BL; Mi XY; Gao YX; Song JY
Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
[TBL] [Abstract][Full Text] [Related]
16. [Importance of PCNA proliferating fraction and histomorphologic prognostic factors for survival in breast cancer].
Schönborn I; Minguillon C; Möhner M; Ebeling K
Pathologe; 1993 Dec; 14(6):307-12. PubMed ID: 7907179
[No Abstract] [Full Text] [Related]
17. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
[TBL] [Abstract][Full Text] [Related]
19. The prognostic relevance of estimates of proliferative activity in early breast cancer.
Heatley MK; Maxwell P; Whiteside C; Ewing P; Toner PG
Histopathology; 2005 Jan; 46(1):110-1. PubMed ID: 15656896
[No Abstract] [Full Text] [Related]
20. Over expression of RhoA is associated with progression in invasive breast duct carcinoma.
Ma L; Liu YP; Geng CZ; Wang XL; Wang YJ; Zhang XH
Breast J; 2010; 16(1):105-7. PubMed ID: 19912238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
